semaglutide

3 statements across 2 episodes · 3 bullish · 0 bearish · 2 people on the record · first statement Dec 29, 2023 by Chamath Palihapitiya · said 6 times in 3 episodes since 2024 · across every show →

Mentions by year

brought up most by Dave Ricks (4), Jason Calacanis (1), Dr. Mehmet Oz (1)

tap a year for its mentions
002141202420252026episodesmentions
011202420252026episodes it came up in
0020.541202420252026episodesmentions per episode
2026 1 mention in 1 episode
2025 1 mention in 1 episode
2024 4 mentions in 1 episode

every mention, scene by scene, with the transcript →

Everything said about semaglutide, oldest first

Dec 29, 2023 bullish
Prediction Not checkable as stated
Chamath: GLP-1 drugs like semaglutide are here to stay and transformational
“And I think these semiglutide GLP ones are here to stay. They're transformational on society.”
Chamath Palihapitiya Dec 29, 2023 ▶ 47:44 E159: The Bestie Awards! Recapping the best and worst of 2023
Oct 8, 2024 bullish
Assertion Supported
Eli Lilly oral GLP-1 shows efficacy matching high-dose semaglutide in trials
“In our hands, it, it's about as good as high dose semaglutide, and we, we're doing phase three right now. So that will start to read out next year.”
Dave Ricks Oct 8, 2024 ▶ 36:44 Dave Ricks, CEO of Eli Lilly | The All-In Interview
Oct 8, 2024 positive
Assertion Supported
Ricks: Novo Nordisk's higher semaglutide dosing enabled obesity treatment
“So it was really Novo's insight that we could push up the dose of semaglutide that allowed the obesity Kind of threshold to be pushed.”
Dave Ricks Oct 8, 2024 ▶ 18:34 Dave Ricks, CEO of Eli Lilly | The All-In Interview
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 460 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.